Literature DB >> 24238816

Dual-energy contrast-enhanced digital mammography in routine clinical practice in 2013.

S Badr1, N Laurent2, C Régis3, L Boulanger4, S Lemaille3, E Poncelet2.   

Abstract

To date, analysis of the vascularisation of breast lesions mainly relies on MR imaging. However, the accessibility of MRI is sometimes limited and has led to the development of new means of imaging, such as dual-energy contrast-enhanced mammography, which provides data on the vascularisation of the breast along with the usual morphological information. The purpose of this paper is to present this new imaging technique as well as the recent references, illustrated by clinical reports derived from our everyday practice to focus on the advantages and disadvantages of this new breast exploration. Dual-energy contrast-enhanced mammography is a recent, seemingly promising technique, in the management of breast cancer. The main advantages consist of its easy installation, the good tolerance and the comfort in the interpretation of difficult to read mammograms. However, the indications and the role of dual-energy contrast-enhanced mammography still have to be determined within the diagnostic strategy of breast tumours. New studies are expected, especially to compare dual-energy contrast-enhanced mammography with breast MRI.
Copyright © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Breast cancer; Diagnosis; Dual-energy contrast-enhanced mammography; MRI; Mammography

Mesh:

Substances:

Year:  2013        PMID: 24238816     DOI: 10.1016/j.diii.2013.10.002

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  13 in total

1.  Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone.

Authors:  A V Chudgar; E F Conant; S P Weinstein; B M Keller; M Synnestvedt; P Yamartino; E S McDonald
Journal:  Clin Radiol       Date:  2017-03-17       Impact factor: 2.350

2.  Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.

Authors:  Alexandra Tsigginou; Christina Gkali; Athanasios Chalazonitis; Eleni Feida; Dimitrios Efthymios Vlachos; Flora Zagouri; Ioannis Rellias; Constantine Dimitrakakis
Journal:  Br J Radiol       Date:  2016-08-09       Impact factor: 3.039

3.  Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.

Authors:  María Del Mar Travieso-Aja; Daniel Maldonado-Saluzzi; Pedro Naranjo-Santana; Claudia Fernández-Ruiz; Wilsa Severino-Rondón; Mario Rodríguez Rodríguez; Víctor Vega Benítez; Octavio Pérez-Luzardo
Journal:  Radiol Med       Date:  2019-06-27       Impact factor: 3.469

4.  Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.

Authors:  Shadi Aminololama-Shakeri; Craig K Abbey; Peymon Gazi; Nicolas D Prionas; Anita Nosratieh; Chin-Shang Li; John M Boone; Karen K Lindfors
Journal:  Eur J Radiol       Date:  2015-10-01       Impact factor: 3.528

5.  Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.

Authors:  Marc B I Lobbes; Ulrich Lalji; Janneke Houwers; Estelle C Nijssen; Patty J Nelemans; Lori van Roozendaal; Marjolein L Smidt; Esther Heuts; Joachim E Wildberger
Journal:  Eur Radiol       Date:  2014-04-03       Impact factor: 5.315

6.  Rapid Access to Contrast-Enhanced spectral mammogRaphy in women recalled from breast cancer screening: the RACER trial study design.

Authors:  L M F H Neeter; I P L Houben; P J Nelemans; T J A Van Nijnatten; R M Pijnappel; C Frotscher; M Osinga-de Jong; F Sanders; T Van Dalen; H P J Raat; B A B Essers; J E Wildberger; M L Smidt; M B I Lobbes
Journal:  Trials       Date:  2019-12-23       Impact factor: 2.279

7.  Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.

Authors:  U C Lalji; I P L Houben; R Prevos; S Gommers; M van Goethem; S Vanwetswinkel; R Pijnappel; R Steeman; C Frotscher; W Mok; P Nelemans; M L Smidt; R G Beets-Tan; J E Wildberger; M B I Lobbes
Journal:  Eur Radiol       Date:  2016-04-20       Impact factor: 5.315

8.  Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.

Authors:  Valentina Iotti; Sara Ravaioli; Rita Vacondio; Chiara Coriani; Sabrina Caffarri; Roberto Sghedoni; Andrea Nitrosi; Moira Ragazzi; Elisa Gasparini; Cristina Masini; Giancarlo Bisagni; Giuseppe Falco; Guglielmo Ferrari; Luca Braglia; Alberto Del Prato; Ivana Malavolti; Vladimiro Ginocchi; Pierpaolo Pattacini
Journal:  Breast Cancer Res       Date:  2017-09-11       Impact factor: 6.466

9.  Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis.

Authors:  Matteo Basilio Suter; Filippo Pesapane; Giorgio Maria Agazzi; Tania Gagliardi; Olga Nigro; Anna Bozzini; Francesca Priolo; Silvia Penco; Enrico Cassano; Claudio Chini; Alessandro Squizzato
Journal:  Breast       Date:  2020-06-10       Impact factor: 4.380

10.  Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study.

Authors:  Anna Bozzini; Luca Nicosia; Giancarlo Pruneri; Patrick Maisonneuve; Lorenza Meneghetti; Giuseppe Renne; Andrea Vingiani; Enrico Cassano; Mauro Giuseppe Mastropasqua
Journal:  Breast Cancer Res Treat       Date:  2020-08-28       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.